Abstract
Studies report a high 28-day all-cause mortality rate in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The specific prognostic value of lymphocyte subsets for critically ill patients remains unclear. We aimed to evaluate the association between lymphocyte subsets and 28-day all-cause mortality in patients with AECOPD admitted to the intensive care unit (ICU). We conducted a retrospective cohort study on patients with severe AECOPD admitted to our hospital from January 2022 to December 2025. Comparisons were made between the survivors and non-survivors. We used restricted cubic splines, and Receiver Operating Characteristic (ROC) curves to describe the association between lymphocyte-related indicators and 28-day all-cause mortality. To prevent overfitting and robustly identify independent risk factors, Boruta feature selection and LASSO regression were sequentially utilized, followed by multivariable logistic regression to construct a prognostic model. The study enrolled 382 patients. During the 28-day follow-up, 115 (30.1%) patients died, and 267 (69.9%) survived. Among all examined immune cells, the CD3 + CD4+ T lymphocyte count demonstrated the strongest predictive performance. CD3 + CD4+ T lymphocytes exhibited the best predictive performance with a cutoff value of 157.61/µL. A prognostic model incorporating CD3 + CD4+ T lymphocytes and other key clinical features showed excellent discriminative ability with an area under the curve (AUC) of 0.860. A marked decline in CD3 + CD4+ T lymphocytes (< 157.61/µL) is a significant and readily accessible independent risk factor for 28-day all-cause mortality in patients with AECOPD admitted to the ICU. A nomogram based on the multivariable logistic regression model provides a practical tool for early risk stratification and targeted immune monitoring in critical care settings.
Similar content being viewed by others
Funding
The authors declare that no financial support was received for the conduct of this study or the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The present study protocol was reviewed and approved by the Institutional Review Board of the First Affiliated Hospital of Zhengzhou University (approval No.2025-KY-0226). All study procedures were performed in accordance with the relevant ethical guidelines and regulations, including the Declaration of Helsinki (2024 version).
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Zhang, W., Zhang, Y., Huo, W. et al. Decreased CD3 + CD4+ T lymphocyte count predicts 28-day all-cause mortality in severe AECOPD patients admitted to the ICU: a retrospective cohort study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-48465-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-48465-8
